In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

A new report published in the journal Communications Medicine suggests Pfizer’s (PFE) Paxlovid may help some long Covid patients, but which ...

Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS ...

Penn has reached an agreement to resolve a dispute over Covid-19 royalties the Philadelphia university alleged it was owed.

Why Kirk Spano sees Pfizer as one of the next big winners from AI and why he thinks investors should be selling cash secured ...

Sangamo Therapeutics shares lost more than half their value when Pfizer pulled out of a collaboration agreement.

Whatever the case, the fundamentals of a politically supportive backdrop for Novavax’s traditional approach to vaccines could easily boost NVAX stock under Trump’s second administration. With that in ...

“We are committed to exploring the optimal path forward for this important treatment, including seeking the right partner with the focus and understanding of the genomic medicine commercial ...

The MBK Scholarship Foundation was established in 2007 by Chairman Kim Byung-joo of MBK Partners to financially support ...

The stock even missed the weight loss drugs craze as the company doesn’t make such medicine. Amidst this gloom ... 80 hedge fund portfolios held PFE at the end of the third quarter which ...